Страна: Нова Зеландія
мова: англійська
Джерело: Ministry for Primary Industries
benazepril hydrochloride
Kela N.V.
benazepril hydrochloride
benazepril hydrochloride 100 g/kg
Cardiovascular agent
ACVM Registered
2013-10-31
W~ .s tJHt 1- 9140T~mse T. +32 J JSJ 08 S7 ·F . +12 37 60 10 11 ~ tnc la . detc ot.H••tk olor-dntk..bt 7F89013E17 BIJSLUITER: KELAPRIL 20 MG FORMAAT: 140 X 205 MM BEDRUKKING: RECTO/VERSO ZWART FOR ANIMAL TREATMENT ONLY RESTRICTED VETERINARY MEDICINE KELAPRIL 20 MG ""'• FILM-COATED TABLETS FOR DOGS Benazepril hydrochloride ACTIVE INGREDIENT AND QUANTITIES Each tablet contains 20 mg Benazepril hydrochloride USE CLAIMS PHENIX For the treatment of heart failure (due to mitral regurgitation and dilated cardiomyopathy) and chronic renal insufficiency in dogs. DIRECTIONS FOR USE For oral use only. KELAPRIL should be given once daily, with or without food. The duration of treatment is unlimited. The recommended oral do se is 0.25-0.5 mg benazepril hydrochloride/kg bodyweight, given according to th e following regime: KELAPRIL 20 mg Weight of dog (kg) Standard Dose Double Dose 21 - 40 0.5 tablet 1 tablet 41 - 80 1 tablet 2 tablets The do se may be doubled, still administered once daily, if ju dged clinically necessary and advised by the veterinary surgeon. REGISTRANT/NEW ZEALAND AGENT Registered to KELA N. V. , St. Lenaartseweg 48, 2320 Hoogstraten, BELGIUM, info@kela.be, + 32 3 340 04 11, manufactured in Belgium. New Zealand agent: Phoenix Pharm Distributors Ltd , phoenixvet@xtra.co.nz, + 9 476 73 91 EXPIRY DATE Tablet halves should be used within 2 days. Shelf-life of the veterinary med icinal product as packaged for sale: 36 m ont hs . NET CONTENTS 28 tablets - 98 tablets STORAGE INSTRUCTIONS Keep out of the reach and sight of children. Sto re below 25°C in th e original packaging. Store in a dry place. Each time an unused half tablet is stored, it should be returned to the open blister space and inserted back into the cardboard bo x. ADVERSE EFFECTS, CAUTIONS AND CONTRAINDICATIONS ADVERSE EFFECTS: On rare occasions transient signs of hypotension, such as lethargy and ataxia may occur. SPECIAL PRECAUTIONS FOR USE IN ANIMALS: No evidence of renal toxicity to the product has been observed in dogs during clinical Прочитайте повний документ